Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Kolmakova

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Urologiia I Nefrologiia|January 1, 1990
[Plasma lipids in patients with chronic glomerulonephritis]E V Kolmakova
Laboratornoe Delo|January 1, 1988
[State of the erythrocyte membranes in patients with chronic diseases of the kidneys]E V Kolmakova
Vrachebnoe Delo|August 1, 1989
[Morphofunctional comparisons in chronic glomerulonephritis]E V Kolmakova, A M Ratner
Likars'Ka Sprava|June 1, 1992
[Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma]E V Kolmakova, B I Shulutko, A N Shishkin
Urologiia I Nefrologiia|May 1, 1994
[Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome]A N Shishkin, E V Kolmakova, K V Ashirova
Klinicheskaia Meditsina|June 1, 1990
[Clinical, immunological and morphological evaluation of nephrotic syndrome]A N Shishkin, B I Shulutko, O P Budaĭ, et al.
Terapevticheskii Arkhiv|January 1, 1989
[A case of diabetic glomerulosclerosis associated with chronic glomerulonephritis]A N Shishkin, E V Kolmakova, N N Kulaeva, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report]I V Maev, E V Kolmakova, S N Bardakov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Urologiia I Nefrologiia|January 1, 1990
[Plasma lipids in patients with chronic glomerulonephritis]E V Kolmakova
Laboratornoe Delo|January 1, 1988
[State of the erythrocyte membranes in patients with chronic diseases of the kidneys]E V Kolmakova
Vrachebnoe Delo|August 1, 1989
[Morphofunctional comparisons in chronic glomerulonephritis]E V Kolmakova, A M Ratner
Likars'Ka Sprava|June 1, 1992
[Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma]E V Kolmakova, B I Shulutko, A N Shishkin
Urologiia I Nefrologiia|May 1, 1994
[Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome]A N Shishkin, E V Kolmakova, K V Ashirova
Klinicheskaia Meditsina|June 1, 1990
[Clinical, immunological and morphological evaluation of nephrotic syndrome]A N Shishkin, B I Shulutko, O P Budaĭ, et al.
Terapevticheskii Arkhiv|January 1, 1989
[A case of diabetic glomerulosclerosis associated with chronic glomerulonephritis]A N Shishkin, E V Kolmakova, N N Kulaeva, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report]I V Maev, E V Kolmakova, S N Bardakov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Pageof 2